Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease

Annual Review of Physiology

Volumn 74, Issue , 2012, Pages 13-40

  Alexander, Matthew R ^a   Owens, Gary K ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Arteriogenesis; Atherosclerosis; Mesenchymal stem cells; Pluripotency genes; Vascular injury and repair

Indexed keywords

SMALL INTERFERING RNA;

ANGIOGENESIS; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; EMBRYO DEVELOPMENT; EPIGENETICS; GENE EXPRESSION; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; PHENOTYPE; PHENOTYPIC PLASTICITY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR DISEASE;

ANIMALS; ARTERIES; ATHEROSCLEROSIS; BLOOD VESSELS; CELL DIFFERENTIATION; CHROMATIN; ENVIRONMENT; EPIGENESIS, GENETIC; EPIGENOMICS; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STEM CELLS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; PLURIPOTENT STEM CELLS; VASCULAR DISEASES;

EID: 84857293493     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-012110-142315     Document Type: Article

References (172)

1. Owens GK, Kumar MS, Wamhoff BR. 2004. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84(3):767-801 (Pubitemid 38823766)
2. Carmeliet P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6(4):389-95 (Pubitemid 30208155)
3. Hanahan D. 1997. Signaling vascular morphogenesis and maintenance. Science 277(5322):48-50 (Pubitemid 27450640)
4. Hungerford JE, Little CD. 1999. Developmental biology of the vascular smooth muscle cell. J. Vasc. Res. 36:2-27
5. Wagenseil JE, Mecham RP. 2009. Vascular extracellular matrix and arterial mechanics. Physiol. Rev. 89(3):957-89
6. Li DY, Brooke B, Davis EC, Mecham RP, Sorensen LK, et al. 1998. Elastin is an essential determinant of arterial morphogenesis. Nature 393(6682):276-80 (Pubitemid 28261728)
7. Owens GK. 1995. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 75(3):487-517
8. Somlyo AP, Somlyo AV. 2003. Calcium sensitivity of smooth muscle and non-muscle myosin II: modulation by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 88:1325-68
9. Bentzon JF, Weile C, Sondergaard CS, Hindkjaer J, Kassem M, Falk E. 2006. Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler. Thromb. Vasc. Biol. 26(12):2696-702
10. Bentzon JF, Sondergaard CS, Kassem M, Falk E. 2007. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation 116(18):2053-61 (Pubitemid 350023751)
11. Speer MY, Yang HY, Brabb T, Leaf E, Look A, et al. 2009. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ. Res. 104(6):733-41
12. Hoofnagle MH, Thomas JA, Wamhoff BR, Owens GK. 2006. Origin of neointimal smooth muscle: Weve come full circle. Arterioscler. Thromb. Vasc. Biol. 26(12):2579-81
13. Hoofnagle MH, Wamhoff BR, Owens GK. 2004. Lost in transdifferentiation. J. Clin. Investig. 113(9):1249-51 (Pubitemid 39069920)
14. Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM. 2002. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 160(3):985-1000 (Pubitemid 34224587)
15. Ramaswamy S, Ross KN, Lander ES, Golub TR. 2003. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33(1):49-54 (Pubitemid 36068681)
16. Carmeliet P, Jain RK. 2000. Angiogenesis in cancer and other diseases. Nature 407(6801):249-57
17. Ross R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-9 (Pubitemid 23132154)
18. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. 1987. Compensatory enlargement of human atherosclerotic coronary arteries. N. Engl. J. Med. 316:1371-75 (Pubitemid 17079680)
19. Galis ZS, Khatri JJ. 2002. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 90(3):251-62 (Pubitemid 34633925)
20. Galis ZS, Sukhova GK, Lark MW, Libby P. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions in human atherosclerotic plaques. J. Clin. Investig. 94:2493-503 (Pubitemid 24379627)
21. Hungerford JE, Little CD. 1999. Developmental biology of the vascular smooth muscle cell: building a multilayered vessel wall. J. Vasc. Res. 36:2-27 (Pubitemid 29106803)
22. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, et al. 2008. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3(3):301-13
23. Gabbiani G, Schmid E, Winter S, Chaponnier C, De Chastonay C, et al. 1981. Vascular smooth muscle cells differ from other smoothmuscle cells: predominance of vimentin filaments and a specific-type actin. Proc. Natl. Acad. Sci. USA 78:298-300
24. Owens GK, Thompson MM. 1986. Developmental changes in isoactin expression in rat aortic smooth muscle cells in vivo. Relationship between growth and cytodifferentiation. J. Biol. Chem. 261:13373-80 (Pubitemid 17006921)
25. Rovner AS, Murphy RA, Owens GK. 1986. Expression of smooth muscle and nonmuscle myosin heavy chains in cultured vascular smooth muscle cells. J. Biol. Chem. 261:14740-45 (Pubitemid 17220270)
26. Rovner AS, Thompson MM, Murphy RA. 1986. Two different heavy chains are found in smoothmuscle myosin. Am. J. Physiol. Cell Physiol. 250:861-70
27. Miano JM, Cserjesi P, Ligon K, Perisamy M, Olson EN. 1994. Smooth muscle myosin heavy chain marks exclusively the smooth muscle lineage during mouse embryogenesis. Circ. Res. 75:803-12 (Pubitemid 24323513)
28. Hasegawa Y, Ueda Y, Watanabe M, Morita F. 1992. Studies on amino acid sequences of two isoforms of 17-kDa essential light chain of smoothmuscle myosin from porcine aorta media. J. Biochem. 111:798-803
29. Hansson GK, Jonasson L, Holm J, Claesson-Welsh L. 1986. Class II MHC antigen expression in the atherosclerotic plaque: Smoothmuscle cells expressHLA-DR, HLA-DQand the invariant gamma chain. Clin. Exp. Immunol. 64:261-68 (Pubitemid 16102149)
30. Winder SJ, Sutherland C, Walsh MP. 1991. Biochemical and functional characterization of smooth muscle calponin. Adv. Exp. Med. Biol. 304:37-51
31. Sobue K, Sellers JR. 1991. Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems. J. Biol. Chem. 266:12115-18 (Pubitemid 21907062)
32. Geiger B, Tokuyasu KT, Dutton AH, Singer SJ. 1980. Vinculin, an intracellular protein localized at specialized sites where microfilament bundles terminate at cell membranes. Proc. Natl. Acad. Sci. USA 77:4127-31 (Pubitemid 10022562)
33. Herring BP, Smith AF. 1996. Telokin expression is mediated by a smoothmuscle cell-specific promoter. Am. J. Physiol. Cell Physiol. 270:1656-65
34. van der Loop FTL, Gabbiani G, Kohnen G, Ramaekers FCS, van Eys GJJM. 1997. Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler. Thromb. Vasc. Biol. 17:665-71 (Pubitemid 27169126)
35. Gorenne I, Nakamoto RK, Phelps CP, Beckerle MC, Somlyo AV, Somlyo AP. 2003. LPP, a LIM protein highly expressed in smooth muscle. Am. J. Physiol. Cell Physiol. 285(3):674-85
36. Mericskay M, Parlakian A, Porteu A, Dandre F, Bonnet J, et al. 2000. An overlapping CArG/octamer element is required for regulation of desmin gene transcription in arterial smooth muscle cells. Dev. Biol. 226:192-208
37. Li L, Miano JM, Mercer B, Olson EN. 1996. Expression of the SM22α promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smoothmuscle cells. J. Cell Biol. 132(5):849-59
38. Mack CP, Owens GK. 1999. Regulation of SM α-actin expression in vivo is dependent upon CArG elements within the 5 prime; and first intron promoter regions. Circ. Res. 84:852-61 (Pubitemid 29181493)
39. Kim S, Ip HS, Lu MM, Clendenin C, Parmacek MS. 1997. A serum response factor-dependent transcriptional regulatory program identifies distinct smoothmuscle cell sublineages. Mol. Cell. Biol. 17(4):2266-78 (Pubitemid 27133314)
40. Madsen CS, Regan CP, Hungerford JE, White SL, Manabe I, Owens GK. 1998. Smoothmuscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5 prime;-flanking and first intronic DNA sequence. Circ. Res. 82:908-17 (Pubitemid 28234582)
41. Adam PJ, Regan CR, Hautmann MB, Owens GK. 2000. Positive and negative acting krupple-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle differentiation marker SM22αin vivo. J. Biol. Chem. 275(4):37798-806 (Pubitemid 32004896)
42. Kumar MS, Hendrix J, Johnson AD, Owens GK. 2003. The smooth muscle α-actin gene requires two E-boxes for proper expression in vivo and is a target of class I basic helix-loop-helix proteins. Circ. Res. 92:840-47 (Pubitemid 36542524)
43. Manabe I, Owens GK. 2001. CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo. J. Clin. Investig. 107:823-34 (Pubitemid 32274035)
44. Liu Y, Sinha S, Owens GK. 2003. A transforming growth factor-β control element required for SM α-actin expression in vivo also partially mediates GKLF-dependent transcriptional repression. J. Biol. Chem. 278(48):48004-11 (Pubitemid 37523250)
45. Hautmann M, Madsen CS, Owens GK. 1997. A transforming growth factor β(TGF) control element drives TGF-induced stimulation of SM α-actin gene expression in concert with two CArG elements. J. Biol. Chem. 272(16):10948-56
46. Hautmann M, Adam PJ, Owens GK. 1999. Similarities and differences in smooth muscle α-actin induction by transforming growth factor β in smooth muscle versus non-muscle cells. Arterioscler. Thromb. Vasc. Biol. 19:2049-58 (Pubitemid 29422235)
47. Hautmann M, Thompson MM, Swartz EA, Olson EN, Owens GK. 1997. Angiotensin II-induced stimulation of smoothmuscleα-actin expression by serum response factor and the homeodomain transcription factor MHox. Circ. Res. 81:600-10 (Pubitemid 27432748)
48. Kumar MS, Owens GK. 2003. Combinatorial control of smooth muscle-specific gene expression. Arterioscler. Thromb. Vasc. Biol. 23:737-47 (Pubitemid 36566161)
49. Owens GK, Vernon SM, Madsen CS. 1996. Molecular regulation of smooth muscle cell differentiation. J. Hypertens. 14(Suppl. 5):55-64
50. Firulli AB, Olson EN. 1997. Modular regulation of muscle gene transcription: a mechanism for muscle cell diversity. Trends Genet. 13(9):364-69 (Pubitemid 27376677)
51. Majesky MW. 2003. Decisions, decisions. SRF coactivators and smooth muscle myogenesis. Circ. Res. 92(8):824-26 (Pubitemid 36542522)
52. Miano JM. 2003. Serum response factor: toggling between disparate programs of gene expression. Mol. Cell. Cardiol. 35(6):577-93 (Pubitemid 36681543)
53. Yano H, Hayashi K, Momiyama T, Saga H, Haruna M, Sobue K. 1995. Transcriptional regulation of the chicken caldesmon gene. Activation of gizzard-type caldesmon promoter requires a CArG box-like motif. J. Biol. Chem. 270(40):23661-66
54. Shore P, Sharrocks AD. 1994. The transcription factors Elk-1 and serum response factor interact by direct protein-protein contacts mediated by a short region of Elk-1. Mol. Cell. Biol. 14:3283-91 (Pubitemid 24132741)
55. Mack CP, Thompson MM, Lawrenz-Smith S, Owens GK. 2000. Smoothmuscleα-actinCArGelements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex. Circ. Res. 86:221-32 (Pubitemid 30086184)
56. Sartorelli V, Kurabayashi M, Kedes L. 1993. Muscle-specific gene expression. A comparison of cardiac and skeletal muscle transcription strategies. Circ. Res. 72:925-31 (Pubitemid 23105497)
57. Du KL, Ip HS, Li J, Chen MM, Dandre F, et al. 2003. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol. Cell. Biol. 23(7):2425-37 (Pubitemid 36351024)
58. Yoshida T, Owens GK. 2005. Molecular determinants of vascular smoothmuscle cell diversity. Circ. Res. 96(3):280-91 (Pubitemid 40279902)
59. McDonald OG, Owens GK. 2007. Programming smooth muscle plasticity with chromatin dynamics. Circ. Res. 100(10):1428-41 (Pubitemid 46834755)
60. Croissant JD, Kim JH, Eichele G, Goering L, Lough J, et al. 1996. Avian serum response factor expression restricted primarily to muscle cell lineages is required for α-actin gene transcription. Dev. Biol. 177(1):250-64 (Pubitemid 26252496)
61. Belaguli NS, Schildmeyer LA, Schwartz RJ. 1997. Organization and myogenic restricted expression of the murine serum response factor gene. A role for autoregulation. J. Biol. Chem. 272(29):18222-31 (Pubitemid 27306410)
62. Yoshida T, Hoofnagle MH, Owens GK. 2004. Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle α-actin. Circ. Res. 94(8):1075-82 (Pubitemid 38579702)
63. Li L, Miano JM, Cserjesi P, Olson EN. 1996. SM22α, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ. Res. 78(2):188-95
64. Miano JM, Carlson MJ, Spencer JA, Misr RP. 2000. Serum response factor-dependent regulation of the smooth muscle calponin gene. J. Biol. Chem. 275(13):9814-22 (Pubitemid 30185217)
65. Hoggatt AM, Simon GM, Herring BP. 2002. Cell-specific regulatory modules control expression of genes in vascular and visceral smooth muscle tissues. Circ. Res. 91(12):1151-59 (Pubitemid 36076364)
66. Manak JR, Prywes R. 1993. Phosphorylation of serum response factor by casein kinase II: evidence against a role in growth factor regulation of fos expression. Oncogene 8(3):703-11 (Pubitemid 23093134)
67. Han Z, Li X, Wu J, Olson EN. 2004. Amyocardin-related transcription factor regulates activity of serum response factor in Drosophila. Proc. Natl. Acad. Sci. USA 101(34):12567-72 (Pubitemid 39122064)
68. Wang Z, Wang DZ, Hockemeyer D, McAnally J, Nordheim A, Olson EN. 2004. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428(6979):185-89 (Pubitemid 38374315)
69. Rivera VM, Miranti CK, Misra RP, Ginty DD, Chen RH, et al. 1993. A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates itsDNA-binding activity. Mol. Cell. Biol. 13:6260-73 (Pubitemid 23292620)
70. Chang DF, Belaguli NS, Iyer D, Roberts WB, Wu SP, et al. 2003. Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Dev. Cell 4(1):107-18 (Pubitemid 36105337)
71. Nishida W, Nakamura M, Mori S, Takahashi M, Ohkawa Y, et al. 2002. A triad of serum response factor and the GATA and NK families governs the transcription of smooth and cardiac muscle genes. J. Biol. Chem. 277(9):7308-17 (Pubitemid 34953125)
72. Manabe I, Owens GK. 2001. Recruitment of serum response factor and hyperacetylation of histones at smooth muscle-specific regulatory regions during differentiation of a novel P19-derived in vitro smooth muscle differentiation system. Circ. Res. 88(11):1127-34 (Pubitemid 34132512)
73. McDonald OG, Wamhoff BR, Hoofnagle MH, Owens GK. 2006. Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J. Clin. Investig. 116:36-48 (Pubitemid 43121789)
74. Yoshida T, Sinha S, Dandre F, Wamhoff BR, Hoofnagle MH, et al. 2003. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ. Res. 92:856-64 (Pubitemid 36542526)
75. Cen B, Selvaraj A, Burgess RC, Hitzler JK, Ma Z, et al. 2003. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Mol. Cell. Biol. 23(18):6597-608 (Pubitemid 37075770)
76. Du KL, Chen MM, Li J, Lepore JJ, Mericko P, ParmacekMS. 2004. Megakaryoblastic leukemia factor- 1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells. J. Biol. Chem. 279(17):17578-86 (Pubitemid 38560522)
77. Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, et al. 2001. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105(7):851-62 (Pubitemid 32635087)
78. Chen J, Kitchen CM, Streb JW, Miano JM. 2002. Myocardin: a component of a molecular switch for smooth muscle differentiation. J. Mol. Cell. Cardiol. 34(10):1345-56 (Pubitemid 35244412)
79. Wang Z, Wang DZ, Pipes GC, Olson EN. 2003. Myocardin is a master regulator of smooth muscle gene expression. Proc. Natl. Acad. Sci. USA 100(12):7129-34 (Pubitemid 36706404)
80. Li J, Zhu X, Chen M, Cheng L, Zhou D, et al. 2005. Myocardin-related transcription factor B is required in cardiac neural crest for smoothmuscle differentiation and cardiovascular development. Proc. Natl. Acad. Sci. USA 102(25):8916-21 (Pubitemid 40881053)
81. Oh J, Richardson JA, Olson EN. 2005. Requirement of myocardin-related transcription factor-B for remodeling of branchial arch arteries and smooth muscle differentiation. Proc. Natl. Acad. Sci. USA 102(42):15122-27 (Pubitemid 41513345)
82. Hendrix J, Wamhoff BR, McDonald T, Sinha S, Yoshida T, Owens GK. 2005. 5 prime; CArG degeneracy in smooth muscle α-actin is required for injury-induced gene suppression in vivo. J. Clin. Investig. 115(2):418-27 (Pubitemid 40385483)
83. Hautmann MB, Madsen CS, Owens GK. 1998. Substitution of the degenerate SM (smooth muscle) α-actin CArG elements with c-fos SREs results in increased basal expression but relaxed specificity and reduced angiotensin II inducibility. J. Biol. Chem. 273(14):8398-406 (Pubitemid 28168901)
84. Li S, Wang DZ, Wang Z, Richardson JA, Olson EN. 2003. The serum response factor coactivator myocardin is required for vascular smoothmuscle development. Proc. Natl. Acad. Sci. USA 100(16):9366-70 (Pubitemid 37033934)
85. Pipes GC, Sinha S, Qi X, Zhu C, Gallardo TD, et al. 2005. Stem cells and their derivatives can bypass the requirement of myocardin for smooth muscle gene expression. Dev. Biol. 288:502-13 (Pubitemid 41790758)
86. Hoofnagle MH, Neppl RL, Berzin EL, Pipes GC, Olson EN, et al. 2011. Myocardin is differentially required for the development of smooth muscle cells and cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 300:H1707-21
87. Lockman K, Hinson JS, Medlin MD, Morris D, Taylor JM, Mack CP. 2004. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors. J. Biol. Chem. 279(41):42422-30 (Pubitemid 39372124)
88. Huang J, Cheng L, Li J, Chen M, Zhou D, et al. 2008. Myocardin regulates expression of contractile genes in smooth muscle cells and is required for closure of the ductus arteriosus in mice. J. Clin. Investig. 118(2):515-25 (Pubitemid 351206542)
89. Parmacek MS. 2004. Myocardin-not quite MyoD. Arterioscler. Thromb. Vasc. Biol. 24(9):1535-37
90. Zhou J, Herring BP. 2005. Mechanisms responsible for the promoter-specific effects of myocardin. J. Biol. Chem. 280(11):10861-69 (Pubitemid 40395951)
91. Liu Y, Sinha S, McDonald OG, Shang Y, Hoofnagle MH, Owens GK. 2005. Kruppel-like factor 4 abrogatesmyocardin-induced activation of smoothmuscle gene expression. J. Biol. Chem. 280(10):9719-27 (Pubitemid 40409670)
92. Tang Rh, Zheng XL, Callis TE, Stansfield WE, He J, et al. 2008. Myocardin inhibits cellular proliferation by inhibiting NF-κB(p65)-dependent cell cycle progression. Proc. Natl. Acad. Sci. USA 105(9):3362-67 (Pubitemid 351723558)
93. Cao D, Wang Z, Zhang CL, Oh J, Xing W, et al. 2005. Modulation of smoothmuscle gene expression by association of histone acetyltransferases and deacetylases with myocardin. Mol. Cell. Biol. 25(1):364-76 (Pubitemid 40039826)
94. Parmacek MS. 2008. Myocardin: dominant driver of the smooth muscle cell contractile phenotype. Arterioscler. Thromb. Vasc. Biol. 28(8):1416-17
95. Wang DZ, Olson EN. 2004. Control of smooth muscle development by the myocardin family of transcriptional coactivators. Curr. Opin. Genet. Dev. 14(5):558-66 (Pubitemid 39360304)
96. Cheung P, Allis CD, Sassone-Corsi P. 2000. Signaling to chromatin through histone modifications. Cell 103(2):263-71
97. Hall IM, Shankaranarayana GD, Noma K, Ayoub N, Cohen A, Grewal SI. 2002. Establishment and maintenance of a heterochromatin domain. Science 297(5590):2232-37
98. Suto RK, Clarkson MJ, Tremethick DJ, Luger K. 2000. Crystal structure of a nucleosome core particle containing the variant histone H2A. Z. Nat. Struct. Biol. 7(12):1121-24
99. Qiu P, Li L. 2002. Histone acetylation and recruitment of serum responsive factor and CREB-binding protein onto SM22 promoter during SM22 gene expression. Circ. Res. 90(8):858-65 (Pubitemid 34633877)
100. Yoshida T, Gan Q, Shang Y, Owens GK. 2007. Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters. Am. J. Physiol. Cell Physiol. 292(2):886-95
101. Thomas JA, Deaton RA, Hastings NE, Shang Y, Moehle CW, et al. 2009. PDGF-DD, a novel mediator of smoothmuscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosisprone flow patterns. Am. J. Physiol. Heart Circ. Physiol. 296(2):442-52
102. Pidkovka NA, Cherepanova OA, Yoshida T, Alexander MR, Deaton RA, et al. 2007. Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ. Res. 101:792-801 (Pubitemid 350287194)
103. Litt MD, Simpson M, Gaszner M, Allis CD, Felsenfeld G. 2001. Correlation between histone lysine methylation and developmental changes at the chicken β-globin locus. Science 293(5539):2453-55 (Pubitemid 32917326)
104. Gan Q, Yoshida T, McDonald OG, Owens GK. 2007. Epigeneticmechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells. Stem Cells 25:2-9 (Pubitemid 46052969)
105. Cook CL, Weiser MC, Schwartz PE, Jones CL, Majack RA. 1994. Developmentally timed expression of an embryonic growth phenotype in vascular smooth muscle cells. Circ. Res. 74:189-96 (Pubitemid 24029150)
106. OBrien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, et al. 1993. Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Circ. Res. 73:223-31 (Pubitemid 23212102)
107. Wilcox JN. 1992. Analysis of local gene expression in human atherosclerotic plaques. J. Vasc. Surg. 15:913-16
108. Blank RS, Owens GK. 1990. Platelet-derived growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells. J. Cell Physiol. 142:635-42
109. Corjay MH, Thompson MM, Lynch KR, Owens GK. 1989. Differential effect of platelet-derived growth factor- versus serum-induced growth on smooth muscle α-actin and nonmuscle β-actin mRNA expression in cultured rat aortic smooth muscle cells. J. Biol. Chem. 264:10501-6 (Pubitemid 19161615)
110. Holycross BJ, Blank RS, Thompson MM, Peach MJ, Owens GK. 1992. Platelet-derived growth factor- BB-induced suppression of smooth muscle cell differentiation. Circ. Res. 71:1525-32
111. Thyberg J, Palmberg L, Nilsson J, Ksiazek T, Sjolund M. 1983. Phenotypic modulation in primary cultures of arterial smooth muscle cells: on the role of platelet-derived growth factor. Differentiation 25:156-67 (Pubitemid 14219910)
112. Somasundaram C, Kallmeier RC, Babij P. 1995. Regulation of smooth muscle myosin heavy chain gene expression in cultured vascular smoothmuscle cells by growth factors and contractile agonists. Basic Appl. Mycol. 6:31-36
113. Li X, Van Putten V, Zarinetchi F, Nicks M, Thaler S, et al. 1997. Suppression of smooth muscle α-actin expression by platelet-derived growth factor in vascular smooth-muscle cells involves Ras and cytosolic phospholipase A2. Biochem. J. 327:709-16 (Pubitemid 27487675)
114. Speer MY, Li X, Hiremath PG, Giachelli CM. 2010. Runx2/Cbfa1, but not loss ofmyocardin, is required for smoothmuscle cell lineage reprogramming toward osteochondrogenesis. J. Cell Biochem. 110(4):935-47
115. Clement N, Gueguen M, Glorian M, Blaise R, Andreani M, et al. 2007. Notch3 and IL-1βexert opposing effects on a vascular smooth muscle cell inflammatory pathway in which NF-κB drives crosstalk. J. Cell Sci. 120(Pt. 19):3352-61 (Pubitemid 350028343)
116. Chen CN, Li YS, Yeh YT, Lee PL, Usami S, et al. 2006. Synergistic roles of platelet-derived growth factor-BB and interleukin-1βin phenotypic modulation of human aortic smoothmuscle cells. Proc. Natl. Acad. Sci. USA 103(8):2665-70
117. Yoshida T, Gan Q, Owens GK. 2008. Krüppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Am. J. Physiol. Cell Physiol. 295(5):1175-82
118. Hayashi K, Takahashi M, Nishida W, Yoshida K, Ohkawa Y, et al. 2001. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ. Res. 89(3):251-58 (Pubitemid 34132683)
119. Majesky MW, Dong XR, Regan JN, Hoglund VJ. 2011. Vascular smooth muscle progenitor cells: building and repairing blood vessels. Circ. Res. 108(3):365-77
120. Kawai-Kowase K, Owens GK. 2007. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 292(1):59-69
121. Shimizu RT, Blank RS, Jervis R, Lawrenz-Smith SC, Owens GK. 1995. The smooth muscle α-actin gene promoter is differentially regulated in smoothmuscle versus non-smoothmuscle cells. J. Biol. Chem. 270:7631-43
122. Landerholm TE, Dong X-R, Belaguli N, Schwartz RJ, Majesky MW. 1999. A role for serum response factor in coronary smooth muscle differentiation from proepicardial cells. Development 126(10):2053-62 (Pubitemid 29271691)
123. Geisterfer AA, Peach MJ, Owens GK. 1988. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62:749-56
124. Simper D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM. 2002. Smooth muscle progenitor cells in human blood. Circulation 106(10):1199-204 (Pubitemid 34988636)
125. Deaton RA, Gan Q, Owens GK. 2009. Sp1-dependent activation of KLF4 is required for PDGF-BBinduced phenotypic modulation of smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 296(4):1027-37
126. Stouffer GA, Owens GK. 1994. TGF-βpromotes proliferation of cultured SMC via both PDGF-AAdependent and PDGF-AA-independent mechanisms. J. Clin. Investig. 93:2048-55
127. Boerth NJ, Dey NB, Cornwell TL, Lincoln TM. 1997. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J. Vasc. Res. 34(4):245-59 (Pubitemid 27292644)
128. Berk BC, Vekshtein V, Gordon H, Tsuda T. 1989. Angiotensin II stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 13:305-14 (Pubitemid 19099600)
129. Owens GK, Schwartz SM. 1982. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy and hyperplasia. Circ. Res. 51:280-89 (Pubitemid 12068896)
130. Owens GK. 1993. Determinants of angiotensin II-induced hypertrophy versus hyperplasia in vascular smooth muscle. Drug Dev. Res. 29(2):83-87 (Pubitemid 23175107)
131. Owens GK, Rabinovitch PS, Schwartz SM. 1981. Smooth muscle cell hypertrophy versus hyperplasia in hypertension. Proc. Natl. Acad. Sci. USA 78:7759-63 (Pubitemid 12186642)
132. Regan CP, Adam PJ, Madsen CS, Owens GK. 2000. Molecular mechanisms of decreased smoothmuscle differentiation marker expression after vascular injury. J. Clin. Investig. 106(9):1139-47
133. Wamhoff BR, Hoofnagle MH, Burns A, Sinha S, McDonald OG, Owens GK. 2004. A G/C element mediates repression of the SM22α promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis. Circ. Res. 95(10):981-88 (Pubitemid 39532328)
134. Cherepanova OA, Pidkovka NA, Yoshida T, Gan Q, Adiguzel E, et al. 2009. Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration. Circ. Res. 104:609-18
135. Yoshida T, Kaestner KH, Owens GK. 2008. Conditional deletion of Kr üppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ. Res. 102(12):1548-57
136. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, et al. 2009. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460:705-10
137. Xin M, Small EM, Sutherland LB, Qi X, McAnally J, et al. 2009. MicroRNAs miR-143 and miR- 145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 23(18):2166-78
138. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, et al. 2009. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ. Res. 105(2):158-66
139. Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, et al. 2002. Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat. Med. 8(8):856-63
140. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS. 2009. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137(4):647-58
141. Cho WC, Chow AS, Au JS. 2011. MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol. 8(1):125-31
142. Chen Z, Zeng H, Guo Y, Liu P, Pan H, et al. 2010. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. J. Exp. Clin. Cancer Res. 29:151
143. Zaman MS, Chen Y, Deng G, Shahryari V, Suh SO, et al. 2010. The functional significance of microRNA-145 in prostate cancer. Br. J. Cancer 103(2):256-64
144. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. 2010. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol. Cell 39(3):373-84
145. Chan MC, Hilyard AC, Wu C, Davis BN, Hill NS, et al. 2010. Molecular basis for antagonism between PDGFand theTGFβfamily of signalling pathways by control of miR-24 expression. EMBOJ. 29(3):559-73
146. Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, et al. 2011. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J. Cell Physiol. 226(4):1035-43
147. Shields JM, Christy RJ, Yang VW. 1996. Identification and characterization of a gene encoding a gut enriched Krüppel-like factor expressed during growth arrest. J. Biol. Chem. 271(33):20009-17
148. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663-76 (Pubitemid 44233629)
149. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, et al. 2007. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448(7151):318-24 (Pubitemid 47080337)
150. Jiang J, Chan YS, Loh YH, Cai J, Tong GQ, et al. 2008. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat. Cell Biol. 10(3):353-60 (Pubitemid 351331023)
151. Gabbiani G. 2003. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 200(4):500-3 (Pubitemid 36818250)
152. Yoshida T, Gan Q, Shang Y, Owens GK. 2007. Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters. Am. J. Physiol. Cell Physiol. 292:886-95
153. Kawai-Kowase K, Kumar MS, Hoofnagle MH, Yoshida T, Owens GK. 2005. PIAS1 activates the expression of smooth muscle cell differentiation marker genes by interacting with serum response factor and class I basic helix-loop-helix proteins. Mol. Cell. Biol. 25(18):8009-23 (Pubitemid 41262995)
154. Doi H, Iso T, Yamazaki M, Akiyama H, Kanai H, et al. 2005. HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box. Arterioscler. Thromb. Vasc. Biol. 25(11):2328-34 (Pubitemid 41552650)
155. Fujiu K, Manabe I, Ishihara A, Oishi Y, Iwata H, et al. 2005. Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5. Circ. Res. 97(11):1132-41
156. Liu ZP, Wang Z, Yanagisawa H, Olson EN. 2005. Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin. Dev. Cell 9(2):261-70 (Pubitemid 41051744)
157. Banai S, Wolf Y, Golomb G, Pearle A, Waltenberger J, et al. 1998. PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine. Circulation 97(19):1960-69 (Pubitemid 28222191)
158. Jawien A, Bowen Pope DF, Lindner V, Schwartz SM, Clowes AW. 1992. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin. Investig. 89:507-11
159. Kenagy RD, Hart CE, Stetler-Stevenson WG, Clowes AW. 1997. Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. Circulation 96(10):3555-60 (Pubitemid 27513433)
160. Martinet Y, Bitterman PB, Mornex JF, Grotendorst GR, Martin GR, Crystal RG. 1986. Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity. Nature 319(6049):158-60 (Pubitemid 16189734)
161. Kozaki K, Kaminski WE, Tang J, Hollenbach S, Lindahl P, et al. 2002. Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice. Am. J. Pathol. 161(4):1395-407
162. Sano H, Sudo T, Yokode M, Murayama T, Kataoka H, et al. 2001. Functional blockade of platelet-derived growth factor receptor-β but not of receptor-α prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice. Circulation 103(24):2955-60 (Pubitemid 32578134)
163. Amento EP, Ehsani N, Palmer H, Libby P. 1991. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smoothmuscle cells. Arterioscler. Thromb. 11:1223-30
164. Johnstone SR, Ross J, Rizzo MJ, Straub AC, Lampe PD, et al. 2009. Oxidized phospholipid species promote in vivo differential Cx43 phosphorylation and vascular smooth muscle cell proliferation. Am. J. Pathol. 175(2):916-24
165. Couffinhal T, Duplaa C, Moreau C, Lamaziere JM, Bonnet J. 1994. Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ. Res. 74:225-34 (Pubitemid 24029154)
166. Loppnow H, Libby P. 1990. Proliferating or interleukin 1-activated human vascular smoothmuscle cells secrete copious interleukin 6. J. Clin. Investig. 85(3):731-38 (Pubitemid 20087475)
167. Fabunmi RP, Baker AH, Murray EJ, Booth RF, Newby AC. 1996. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem. J. 315(Pt. 1):335-42 (Pubitemid 26113571)
168. Keen RR, Nolan KD, Cipollone M, Scott E, Shively VP, et al. 1994. Interleukin-1βinduces differential gene expression in aortic smooth muscle cells. J. Vasc. Surg. 20(5):774-84
169. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, et al. 1994. Cytokinestimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 75(1):181-89 (Pubitemid 24187750)
170. Marx N, Neumann FJ, Zohlnhöfer D, Dickfeld T, Fischer A, et al. 1998. Enhancement of monocyte procoagulant activity by adhesion on vascular smooth muscle cells and intercellular adhesion molecule- 1-transfected Chinese hamster ovary cells. Circulation 98(9):906-11 (Pubitemid 28397441)
171. Niwa H, Ogawa K, Shimosato D, Adachi K. 2009. A parallel circuit of LIF signalling pathwaysmaintains pluripotency of mouse ES cells. Nature 460(7251):118-22
172. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, et al. 2005. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122(6):947-56 (Pubitemid 41345211)